Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: NDoC: NOTICE OF APPEAL to the Federal Circuit by TPL 11-4-13
How can this appeal be good? Honestly, are they appealing because it will do PTSC investors good, or are they appealling for the benefit the Leckrone family? Can you elaborate on what happens once the patent ends in 2015 and how that affects the ability to generate licensing revenue . . . . be well
Share
New Message
Please login to post a reply